Home › Research › Vascular contributions
Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease
Daisy Flatman, Richard William Naylor, Siobhan Crilly, I.S.R. CARTER, Mironov Aa, Emmanuel Pinteaux, Stuart McRae Allan, Rachel Lennon et al.. Matrix Biology, 2025-08-20
Topic: Brain proteins, microglia and lab models
Plain-language summary
Cerebral small vessel disease (cSVD) is a major cause of vascular dementia and stroke. Our understanding of cSVD pathophysiology is incomplete and our ability to treat patients is limited. Pathogenic variants in type IV collagen alpha 1 ( COL4A1 ) cause a monogenic form of cSVD with variable age of onset, via disturbance of cerebrovascular basement membranes. Zebrafish larvae are a powerful model organism for studying cerebrovascular disease due to their optical clarity and applicability for live imaging. In this study, we characterised a zebrafish crispant model for loss-of-function COL4A1 -associated cSVD that successfully recapitulates key disease features, including spontaneous intracerebral haemorrhage and cerebrovascular abnormalities. We also identified evidence for abnormal cerebrovascular basement membranes and elevated matrix metalloproteinase 9 ( mmp9) transcription associated with loss of col4a1 . Pharmacological inhibition of mmp9 was sufficient to ameliorate some cerebrovascular phenotypes. Finally, we describe the generation of a mutant line carrying a germline-transmissible 20bp deletion in zebrafish col4a1 ( col4a1 Δ20 ) which is associated with cerebrovascular abnormalities, swimming defects and increased susceptibility to pharmacologically induced brain haemorrhages during larval stages. In adulthood, mutant col4a1 Δ20 animals developed spontaneous brain haemorrhages that were observable in free-swimming fish. Overall, this study validates the use of zebrafish disease modelling for preclinical COL4A1 -associated cSVD research and highlights its potential for further understanding disease pathophysiology and future drug discovery projects.
What this study adds
Evidence grade: Low
This zebrafish study found that loss of col4a1 reproduced features of cerebral small vessel disease, including spontaneous brain hemorrhage and cerebrovascular abnormalities, and that blocking mmp9 reduced some of these effects. Because this is an animal model, the findings are early and do not yet show a treatment for people.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Flatman, D., Naylor, R. W., Crilly, S., CARTER, I., Aa, M., Pinteaux, E., et al. (2025). Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease. Matrix Biology. https://doi.org/10.1016/j.matbio.2025.08.005
Vancouver
Flatman D, Naylor RW, Crilly S, CARTER I, Aa M, Pinteaux E, et al. Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease. Matrix Biology. 2025. doi:10.1016/j.matbio.2025.08.005. PMID: 40846110.
BibTeX
@article{flatman2025-40846110,
author = {Flatman, Daisy and Naylor, Richard William and Crilly, Siobhan and CARTER, I.S.R. and Aa, Mironov and Pinteaux, Emmanuel and Allan, Stuart McRae and Lennon, Rachel and others},
title = {{Loss of col4a1 in zebrafish recapitulates the cerebrovascular phenotypes associated with monogenic cerebral small vessel disease}},
journal = {Matrix Biology},
year = {2025},
doi = {10.1016/j.matbio.2025.08.005},
pmid = {40846110},
url = {https://doi.org/10.1016/j.matbio.2025.08.005}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- We also identified evidence for abnormal cerebrovascular basement membranes and elevated matrix metalloproteinase 9 ( mmp9) transcription associated with loss of col4a1 .
- Finally, we describe the generation of a mutant line carrying a germline-transmissible 20bp deletion in zebrafish col4a1 ( col4a1 Δ20 ) which is associated with cerebrovascular abnormalities, swimming defects and increased susceptibility to pharmacologically induced brain haemorrhages during larval stages.
- Overall, this study validates the use of zebrafish disease modelling for preclinical COL4A1 -associated cSVD research and highlights its potential for further understanding disease pathophysiology and future drug discovery projects.
Why it matters
This zebrafish study found that loss of col4a1 reproduced features of cerebral small vessel disease, including spontaneous brain hemorrhage and cerebrovascular abnormalities, and that blocking mmp9 reduced some of these effects. Because this is an animal model, the findings are early and do not yet show a treatment for people.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Matrix Biology) |
| Journal's citation record | 2 / 4 | Matrix Biology: journal h-index 176 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Laboratory or animal study (title names “zebrafish”) — scores zero |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Paul R. Kasher: h-index 22 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Manchester: institution h-index 1,304 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40846110) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.matbio.2025.08.005
- PubMed: 40846110
- Original source →
- Free full text: Matrix Biology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Vascular contributions from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.